Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen's Q4 Crushed Estimates and Answered 3 Important Questions in the Process
Motley Fool
Fri, 01/29/16 - 10:26 am
Tags:
Amgen, earnings
3 Key Numbers to Monitor When Amgen Reports Fourth-Quarter Results
Motley Fool
Wed, 01/27/16 - 10:19 am
Tags:
Amgen, earnings
Sanofi and Regeneron likely to cough up royalties to end Amgen's PCSK9 patent suit: Analyst
Fierce Pharma
Tue, 01/26/16 - 09:03 pm
Tags:
Sanofi, Regeneron, Amgen, PCSK9 inhibitors, patents, Repatha, Praluent
Amgen's Humira biosim is one step closer to FDA approval. But how close is it to market?
Fierce Pharma
Tue, 01/26/16 - 09:01 pm
Tags:
Amgen, biosimilars, Humira, FDA, AbbVie
FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501
Yahoo
Mon, 01/25/16 - 10:22 pm
Tags:
FDA, Amgen, biosimilars, biologics, ABP 501, Humira
U.S. top court rules for Amgen over employee lawsuit
Yahoo/Reuters
Mon, 01/25/16 - 10:09 am
Tags:
Amgen, employee lawsuits
Big Earnings Expectations For Big Biotech
Yahoo/Benzinga
Sun, 01/24/16 - 09:12 pm
Tags:
earnings, Amgen, Biogen, Celgene
What You Missed at the 2016 J.P. Morgan Healthcare Conference
Motley Fool
Sun, 01/24/16 - 12:25 pm
Tags:
JPMHC 2016, Amgen, Biogen, Celgene
Amgen's Repatha wins first PCSK9 OK in Japan
Fierce Pharma
Sat, 01/23/16 - 11:04 am
Tags:
Amgen, Repatha, PCSK9 inhibitors, Japan
FDA gives full approval to Amgen blood cancer drug
Yahoo/Reuters
Thu, 01/21/16 - 06:18 pm
Tags:
FDA, Amgen, Kyprolis, blood cancer
3 Scorned Biotechs Destined to Rebound
TheStreet.com
Wed, 01/20/16 - 10:25 am
Tags:
Merrimack Pharmaceuticals, Relypsa, Amgen, AbbVie, Dynavax
Amgen Loses Enbrel to Biogen in Europe; Can It Cope?
Bidness, ETC
Tue, 01/19/16 - 10:39 am
Tags:
Amgen, Biogen, Europe, Enbrel, Samsung Bioepis, biosimilars
The Top Biotech Stocks of 2016
Investopedia
Tue, 01/19/16 - 09:23 am
Tags:
biotech, Amgen, Gilead Sciences, Biogen
U.S. patent office rules against Amgen Humira challenge
Yahoo/Reuters
Thu, 01/14/16 - 08:49 pm
Tags:
patents, Amgen, Humira, generics, AbbVie
What public outcry? New year brings dozens of double-digit drug price hikes
Fierce Pharma
Tue, 01/12/16 - 02:38 pm
Tags:
drug pricing, Pfizer, Allergan, Amgen
Amgen: Steady as She Goes
Barron's
Thu, 01/7/16 - 12:46 pm
Tags:
Amgen
Here’s Why Amgen Shares are Likely to Rise this Year
Bidness, ETC
Tue, 01/5/16 - 03:05 pm
Tags:
Amgen, R&D, Repatha, Kyprolis
What Does 2016 Hold for Biotech Stocks?
Motley Fool
Sun, 01/3/16 - 10:27 pm
Tags:
biotech, Gilead Sciences, Celgene, Amgen, Regeneron, Sanofi, Biomarin, Sarepta Th
Gilead, Amgen, Shire: Key Bolt-On Biotech Deal Makers for 2016
Bidness, ETC
Thu, 12/31/15 - 10:24 am
Tags:
Shire, Amgen, Gilead Sciences, M&A
The biosimilars are coming. But how long will it be till they can make their mark?
Fierce Pharma
Sat, 12/26/15 - 08:49 pm
Tags:
biosimilars, Sanofi, Amgen, Eli Lilly

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.